OCT 31·tradingview.comMed
UBS maintains Exponent at Neutral, raises price target to $82 from $72
UBS kept Exponent at Neutral but raised its price target to $82 from $72, a 13.9% increase. This implies a 2.2% upside from the Oct 30 close of $80.26.
StockNASDAQ · US · USDIndustrials · Engineering & Construction
$EXPO
EXPONENT INC
Exponent is a science and engineering consulting firm that helps clients address complex technical problems. Its clients include corporations, law firms, insurance companies, government agencies and organizations across sectors such as consumer products, energy, transportation, chemicals, construction and life sciences. Exponent provides project-based services through 17 practices in two operating segments: Engineering and Other Scientific, and Environmental and Health. Its services include engineering and scientific investigations, failure analysis, product and process safety evaluations, testing, risk assessment, regulatory support, litigation consulting and expert testimony. The firm also advises on product development, environmental and health issues, construction projects and data analysis. It charges clients on a fixed-price or time-and-material basis, with hourly rates based on staff members’ skills and experience. Exponent is headquartered in Menlo Park, California.
AlphAI earnings readThird quarter of fiscal year 2026 · OCT 29Exponent reported third-quarter revenue growth of 18%, revenue-before-reimbursements growth of 12%, and raised full-year revenue and EBITDA-margin guidance.Verdict: strongRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $EXPOvia TradingView
AI sentiment · 7d10 articles
- Bullish
- 8
- Neutral
- 2
- Bearish
- 0
Insider · 30dAll trades →
No SEC Form 4 filings for $EXPO in the last 30 days.
See all $EXPO insider activity →Top stories · $EXPOMore →
OCT 30·tradingview.com
JP Morgan maintains Exponent at Overweight, raises price target to $100 from $90
JP Morgan kept Exponent at Overweight and raised its price target to $100 from $90, an 11.1% increase. The new target implies a 24.6% upside from the Oct 30 close of $80.26, according to the bank.
OCT 30·seekingalpha.com
Exponent forecasts 2026 net revenue growth of 10%–11% as it raises EBITDA margin outlook to 28%–28.3% (NASDAQ:EXPO)
Exponent, Inc. (EXPO) forecasts 2026 net revenue growth of 10%–11% and raises EBITDA margin outlook to 28%–28.3%. The company's updated financial guidance may impact investor expectations.
EXPO sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 10 news stories mentioning EXPO (EXPONENT INC). Coverage has skewed bullish: 8 bullish, 2 neutral, and 0 bearish.
Recent EXPO coverage spans earnings, financial news and insider activity.
What's driving EXPO
Analyst upgrade suggests upside potential.
Analyst upgrade suggests upside potential.
Guidance lift suggests improved profitability and growth, likely supporting the stock.
Beat on both EPS and revenue should support near-term sentiment, with focus shifting to whether Q4 fiscal 2026 revenue guidance confirms strength.
Raised guidance suggests stronger earnings outlook, likely supporting the stock.
AlphAI scores every news story that mentions EXPO with an AI model for sentiment and relevance, and aggregates insider trades from EXPONENT INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $EXPO
Score
UBS maintains Exponent at Neutral, raises price target to $82 from $72
UBS kept Exponent at Neutral but raised its price target to $82 from $72, a 13.9% increase. This implies a 2.2% upside from the Oct 30 close of $80.26.
1 min readJP Morgan maintains Exponent at Overweight, raises price target to $100 from $90
JP Morgan kept Exponent at Overweight and raised its price target to $100 from $90, an 11.1% increase. The new target implies a 24.6% upside from the Oct 30 close of $80.26, according to the bank.
1 min read
Exponent forecasts 2026 net revenue growth of 10%–11% as it raises EBITDA margin outlook to 28%–28.3% (NASDAQ:EXPO)
Exponent, Inc. (EXPO) forecasts 2026 net revenue growth of 10%–11% and raises EBITDA margin outlook to 28%–28.3%. The company's updated financial guidance may impact investor expectations.
1 min readExponent GAAP EPS of $0.64 beats by $0.04, revenue of $173.7M beats by $20.27M (NASDAQ:EXPO)
Exponent reported Q3 GAAP EPS of $0.64, beating estimates by $0.04, and revenue of $173.7M, exceeding expectations by $20.27M. The company anticipates revenue growth for Q4. According to Exponent.
3 min readExponent Reports Third Quarter 2026 Financial Results
EXPONENT INC (EXPO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Exponent Reports Third Quarter 2026 Financial Results MENLO PARK, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2026 ended October 2, 2026. “Exponent delivered another str
2 min read
Analysts Offer Insights on NA Companies: Exponent (EXPO) and Generac Holdings (GNRC)
Analysts from William Blair and Stifel Nicolaus maintained Buy ratings on Exponent (EXPO) and Generac Holdings (GNRC) respectively. EXPO has a Strong Buy consensus and $84.00 price target, while GNRC has a Moderate Buy consensus and $295.79 price target, reflecting a 42.3% upside. Both stocks closed at $64.53 and $212.22 last Tuesday.
1 min readSouri Shukri Jeries purchased $13K of EXPO
Souri Shukri Jeries (Group Vice President) purchased 184 shares of EXPONENT INC (EXPO) at $68.45 on 2026-09-18.
1 min read
Expo Engineering and Projects Ltd receives order worth Rs. 18.51 crore
Expo Engineering and Projects Ltd said it received an order dated Aug 10, 2026 from Indian Oil Corp Ltd (Pipelines Division, Western Region Pipelines, Rajkot) worth Rs. 18.51 crore including taxes. The work covers Maintenance and Inspection of crude oil storage tank VT-08 at WRPL, Viramgam. The BSE stock last traded at Rs. 82.29.
2 min read
Exponent (EXPO) Q2 2026 Earnings Call Transcript
Exponent, Inc. (EXPO) reported Q2 2026 net revenues of $148.9 million, up 12% from $132.9 million a year earlier, and net income of $29.4 million, up 11%. Diluted EPS was $0.60. Management raised FY 2026 revenue guidance to 9% to 10% growth and EBITDA margin to 27.8% to 28.1%, and authorized an additional $50 million for share repurchases.
6 min readExponent Q2 Earnings Call Highlights
Exponent (NASDAQ:EXPO) reported Q2 EBITDA up 16% to $42.7 million, with EBITDA margin at 28.7% of net revenue versus 27.8% a year earlier. Billable hours rose 8% to about 390,000 and utilization increased to 74%. The company repurchased $67.4 million of stock and paid $14.8 million in dividends. It raised 2026 outlook for net revenue growth of 9% to 10%.
6 min read